Study uncovers new molecule involved in regeneration of acute liver wounds

NewsGuard 100/100 Score

A new study from researchers of CEDOC-NOVA Medical School|Faculdade de Ciências Médicas and Instituto Gulbenkian de Ciência, led by Maria Paula Macedo and Carlos Penha-Gonçalves, respectively, published in Hepatology Communications, showed that a molecule CD26/DPP-4 is involved in the regeneration of acute liver wounds and is a promising biomarker for hepatic disease.

It is known that DPP-4 regulates insulin secretion upon food intake. The regulation of the levels of "sugar in the blood" in type-2 diabetics is performed by therapeutic inhibition of enzymatic activity of the molecule CD26/DPP-4. This approach has earned clinical relevance. Moreover, apart from its role in the control of the amount of sugar present in blood, the molecule DPP4 appears to be related with inflammatory reactions in various pathological processes.

In this study, the researchers explored the role of CD26/DPP-4 during injury of the hepatic tissue leading to evident reduction of the main liver immune cell population (Kupffer cells). It was shown that the blood levels of CD26/DPP-4 enzymatic activity are augmented when this population of liver immune cells is diminished, both in acute and chronic mouse models of liver injury. Inversely, the levels of blood enzymatic activity decreased during recovery of these cells. The authors observed that specific deletion of such immune liver cell population in absence of liver tissue damage also lead to significant increase in CD26/DPP4 blood enzymatic activity. Thus, these results show the close relation between functional changes in Kupffer cells associated with hepatic diseases and the molecule CD26/DPP-4.

The relation between the liver immune cells and the enzymatic activity of CD26/DPP-4 in the blood, exhibited in this study, suggests that the level/amount of the enzymatic activity of the molecule CD26/DPP-4 in the blood might be used as a biomarker. Moreover, it can become a valuable biochemical parameter for the evaluation of hepatic lesion or disorder since so far can this evaluation can only be performed using invasive techniques.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Newly discovered molecule may be a potential therapeutic target for triple-negative breast cancer